Antipas, Leonardo A.

HRN: 21-53-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2022
CEFUROXIME 1.5GM (VIAL)
07/09/2022
07/16/2022
IV
1.5g
Q8
UTI
Waiting Final Action 
07/10/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/10/2022
07/16/2022
IV
1.5 G
Q8H
Cellulitis, Right Leg
Waiting Final Action 
07/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/10/2022
07/16/2022
IV
600 Mg
Q8H
Cellulitis, Right Leg
Waiting Final Action 
07/14/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/14/2022
07/21/2022
IV
1.5g
Q6
Cellulitis, Right Leg
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: